Sept. 15, 2021 – For My Lung Health, the joint American Thoracic Society and American College of Chest Physicians (CHEST) campaign, is the winner of this year’s Pharmaceutical Executive APEX Awards in the respiratory category. The campaign, made possible by an educational grant from GlaxoSmithKline with additional support from Boehringer Ingelheim Pharmaceuticals, Inc., was launched in response to COVID-19.
For My Lung Health targeted individuals with lung disease, reminding them of the importance of continuing to prioritize their health in the face of the pandemic. The campaign had a strong focus on people of color (POCs) who continue to be disproportionately affected by COVID-19 and have higher rates of chronic lung conditions, a reminder of the inequities POCs face in accessing care. The campaign’s success was marked by impressive audience engagement with its dual-language web content and videos. Within six weeks of its launch, the video created for the campaign had over 2.6 million views and 40 percent of those views were for the version that was translated into Spanish.
“As COVID-19 hospitalizations continue to rapidly increase due to the highly contagious Delta variant, the For My Lung Health campaign’s message is even more important, as individuals with chronic lung diseases remain highly vulnerable,” said ATS President Lynn Schnapp, MD, ATSF. “The campaign’s focus on people of color in particular is vital to ensure they have access to accurate information to make informed decisions.”
“Public education is critical to ensure the wellbeing of those with preexisting lung conditions and CHEST is proud to receive this award and celebrate the success of this campaign,” says CHEST President Steven Q. Simpson, MD, FCCP. “With COVID cases surging across the country, the For My Lung Health campaign is as relevant today as it was when it was first launched in the summer of 2020.”
ATS and CHEST would like to acknowledge support from Glue Advertising in launching the For My Lung Health campaign.
Share Via Twitter: The votes are in and the #Formylunghealth campaign has won the Pharmaceutical Executive Apex Awards. #lunghealth #covid19 @atscommunity @accpchest
About the American Thoracic Society Founded in 1905, the American Thoracic Society is the world’s leading medical society dedicated to accelerating the advancement of global respiratory health through multidisciplinary collaboration, education, and advocacy. Core activities of the Society’s more than 16,000 members are focused on leading scientific discoveries, advancing professional development, impacting global health, and transforming patient care. Key areas of member focus include developing clinical practice guidelines, hosting the annual International Conference, publishing four peer-reviewed journals, advocating for improved respiratory health globally, and developing an array of patient education and career development resources.
Please visit our website to learn more.
About the American College of Chest Physicians
The American College of Chest Physicians® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care, and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST®, visit chestnet.org.
